This Article Free Full Text (Free PDF) Free References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Web of Science (5) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Ponsky, L. E. Articles by Novick, A. C. Search for Related Content PubMed PubMed Citation Articles by Ponsky, L. E. Articles by Novick, A. C. Social Bookmarking                         What's this?

Renal Radiosurgery: Initial Clinical Experience With Histological Evaluation

Center for Urologic Oncology and Minimally Invasive Therapies, University Hospitals Case Medical Center, lee.ponsky{at}uhhospitals.org

Arul Mahadevan, MD

Department of Radiation Oncology, Cleveland Clinic, Ohio

Indebir S. Gill, MD

Glickman Urological Institute, Cleveland Clinic, Ohio

Toufik Djemil, PhD

Department of Radiation Oncology, Cleveland Clinic, Ohio

Andrew C. Novick, MD

Glickman Urological Institute, Cleveland Clinic, Ohio

The purpose of this study was to determine whether radiosurgical technology can be safely applied to renal tumors. Patients received radiosurgical treatment of renal lesions. At 8 weeks after radiosurgical treatment, patients underwent a partial or radical nephrectomy and histologic evaluation. The patients received a radiation dose of 4 Gy per fraction for 4 fractions. Patients were followed, and radiation-induced toxicities were noted. Three patients were treated for a minimum of 1 year of follow-up. All patients completed the treatments, tolerating each of the 4 fractions with no adverse events. No acute toxicities or changes in renal function were noted. None of the patients had any evidence of acute radiation injury or toxicity noted at the time of surgery or within the subsequent 12 months after the radiosurgical treatment. The last patient treated was found to have a cavity with no microscopic evidence of viable tumor after radiosurgical treatment; pathology was consistent with necrotic renal cell carcinoma, papillary type. The other 2 tumors demonstrated pathologic evidence of viable renal cell carcinoma (grade I and grade II). Tumor size remained relatively unchanged for 8 weeks after the radiosurgical treatment in all patients. The authors are extremely encouraged and cautiously optimistic with the initial results. Radiosurgery for renal tumors appears to be safe at this initial dose level.

Key Words: renal cancer • ablation • radiation • radiosurgery

Surgical Innovation, Vol. 14, No. 4, 265-269 (2007)
DOI: 10.1177/1553350607310546


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?